-
Joel Graber, Ph.D., Joins MDI Biological Laboratory As Senior Staff Scientist
Apr 28, 2017, 16:20 PM by Michael CroftBAR HARBOR, ME, UNITED STATES - Apr 28, 2017 - The MDI Biological Laboratory has announced that Joel Graber, Ph.D., will join the faculty as a senior staff scientist as of May 2Full story -
Rgenix Appoints Chief Medical Officer
Apr 27, 2017, 16:39 PM by Michael CroftNEW YORK, NY - Apr 27, 2017 - For Immediate ReleaseRgenix, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and antibody cancer therapeutics, announced today the appointment of Roger Waltzman, MFull story -
Personalis, Dovetail Genomics, DataDirect Networks, And More: News From April 2017
Apr 27, 2017, 15:15 PM by Michael CroftBio-IT World Brief | News, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Personalis, Dovetail Genomics, DataDirect Networks, and more.Full story -
Record growth for life science tech firm as MES adoption increases globally
Apr 27, 2017, 04:26 AM by Michael Croft- Apr 27, 2017 - A global life science technology firm has surpassed the €20 million milestone for sales of its manufacturing execution system (MES) servicesFull story -
BioRxiv Preprint Server Gets Cash Boost From Chan Zuckerberg Initiative
Apr 26, 2017, 15:47 PM by Michael CroftNature News & Comment | Money will be used to develop open-source platform and help put articles in web-friendly formats.Full story -
NovaSeq Orders Bring Pleasant Surprises, Says deSouza
Apr 26, 2017, 10:45 AM by Michael CroftFull storyBio-IT World Illumina held its first quarter earnings calls yesterday. Francis deSouza, President and CEO, reported that the launch of the company’s new sequencing platform, NovaSeq, “surpassed our expectations, with more than 135 orders in Q1.” “As far out as we can see, there’s an insatiable demand for high throughput sequencing,” deSouza said.
-
Four Decades Of Hacking Biotech And Yet Biology Still Consumes Everything
Apr 26, 2017, 10:05 AM by Michael CroftForbes | Computer-aided drug design is a key contributor to pharma R&D today, but its just one of many contributors. Biology still consumes everything, and is the real constraint on developing new medicines today. Healthy, realistic skepticism regarding recent "software-eats-biotech" claims is needed.Full story -
Concept Life Sciences further expands its service offering by investing in Micro Chamber and Thermal Extraction Facilities
Apr 26, 2017, 08:57 AM by Michael CroftMANCHESTER, UNITED KINGDOM - Apr 26, 2017 - Concept Life Sciences has further expanded its analytical testing capabilities by making significant investment into Micro Chamber and Thermal Extraction facilities, used to sample VOCs or SVOCs emitted from products and materialsFull story -
MR Solutions wins second Queen’s Award for Enterprise
Apr 26, 2017, 08:55 AM by Michael CroftGUILDFORD, UNITED KINGDOM - Apr 26, 2017 - MR Solutions, of Guildford has won the prestigious Queens Award for Enterprise for International TradeFull story -
Future of Surfactants Summit North America
Apr 26, 2017, 04:41 AM by Michael CroftCHICAGO, IL - Sep 27, 2017 - Future of Surfactants Summit North America, 27th & 28th September 2017, Chicago, ILThe Impact of Evolving Trends, Environmental Standards &Consumer Preferences on the Demand of Specialty SurfactantsFull story
Following the success of our two European editions and inaugural North American version last year, we are pleased to announce the 2nd edition of our Future of Surfactants Summit North America will take place on the 27th & 28th September 2017, in Chicago, IL -
Genomenon Wins $1.8M NIH Grant To Automatically Curate Genomic Literature
Apr 25, 2017, 16:25 PM by Michael CroftFull storyBio-IT World Brief | Genomenon today announced a $1.8M grant awarded by the National Institutes of Health. The fast-track Small Business Innovation Research grant, awarded by the National Human Genome Research Institute, will fund Genomenon's further innovation in genomic analysis, efficiently streamlining the laborious literature research and curation process leading to faster patient diagnosis.
-
Biotech Is The New Digital Says MIT Media Lab Founder
Apr 25, 2017, 12:39 PM by Michael CroftDezeen | Biotechnology is going to "govern the next decade of thought" at research institutions like the MIT Media Lab, says its founder Nicholas Negroponte.Full story -
Recipharm appoints Henrik Stenqvist as new Chief Financial Officer
Apr 25, 2017, 09:57 AM by Michael CroftSTOCKHOLM, SWEDEN - Apr 11, 2017 - Recipharm AB today announced the appointment of Henrik Stenqvist as Recipharms new Executive Vice President and Chief Financial Officer, effective on April 24, 2017Full story -
DNA Tests and Sometimes Surprising Results
Apr 24, 2017, 10:40 AM by Michael CroftThe New York Times | Think you know your racial background? A communications studies project involving ancestry DNA testing has led to interesting conversations on identity.Full story -
Hannes Smarason On The Future Of The Platform For WuXi NextCODE
Apr 24, 2017, 10:10 AM by Michael CroftDiagnostics World | Hannes Smarason, WuXi NextCode's new CEO, is looking to enable the use of the WuXi NextCode platform across a multitude of applications. The goal is to create a Contract Genomics Organization, an underlying platform for genomic data that brings together everything needed to empower healthcare.Full story -
Biogen Says Its Back and Ready for ‘Highly Active’ Dealmaking
Apr 24, 2017, 09:42 AM by Michael CroftBloomberg | Biogen Inc. is ready to make some deals. "We're moving, and we're back in terms of augmenting the pipeline," research and development head Michael Ehlers said Friday in an interview. An agreement last week to pay Bristol-Myers Squibb Co. $300 million upfront for an experimental Alzheimer's drug is "hopefully just the beginning of a set of very rigorous but highly active deals."Full story -
Recipharm opens new GMP suite for clinical trial material
Apr 24, 2017, 09:26 AM by Michael CroftNORTH CAROLINA, NC - Apr 24, 2017 - Recipharm, the contract development and manufacturing organisation (CDMO), has opened a newly built GMP suite for clinical trial material (CTM) manufacture at its facility in Research Triangle Park, North Carolina, USAFull story -
Recipharm delivers first serialised batch to Saudi Arabia
Apr 21, 2017, 11:50 AM by Michael CroftLISBON, PORTUGAL - Apr 21, 2017 - Recipharm, the contract development and manufacturing organisation (CDMO), has delivered its first batch of serialised drug products to Saudi Arabia, following the introduction of new regulatory requirements in March 2017Full story -
World’s largest society for regulatory professionals increases investment in Europe
Apr 21, 2017, 10:46 AM by Michael Croft- Apr 20, 2017 - The Regulatory Affairs Professionals Society (RAPS) is stepping up its presence in Europe and expanding its European team in response to growing membership demand from those involved with the regulation of healthcare and related productsFull story -
The Go-To Gene Sequencing Machine With Very Strange Results
Apr 21, 2017, 10:31 AM by Michael CroftWIRED | An update to Illumina's gene sequencing technology could have contaminated the results of recent high-sensitivity data produced on the machines.Full story